We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Renal Cancer Current Status and Innovations

    Renal Cancer: Current Status and Innovations provides a useful guide to the fundamental basics and latest diagnostic and treatment techniques for...

    Christopher Anderson, Mehran Afshar
    Book 2022
  2. Robotic Surgery for Renal Cancer

    This latest book in the Management of Urology Series provides insight into how to appropriately manage patients undergoing pelvic robotic urological...
    Sanchia S. Goonewardene, Raj Persad, David Albala in Management of Urology
    Book 2022
  3. Genomic alterations and diagnosis of renal cancer

    The application of molecular profiling has made substantial impact on the classification of urogenital tumors. Therefore, the 2022 World Health...

    **ngming Zhang, Hella A. Bolck, ... Holger Moch in Virchows Archiv
    Article Open access 24 November 2023
  4. The research landscape of renal cancer ablation

    Background

    Renal ablation has emerged as a minimally invasive treatment option for kidney cancer. This systematic review uses bibliometric analysis to...

    Hassan Mahmood, Avinash Deshwal, Aleena Khalid in Journal of Medical Imaging and Interventional Radiology
    Article Open access 18 June 2024
  5. Percutaneous Renal Surgery

    In the ever-evolving field of urology, percutaneous renal surgery (PCNL) for kidney stones stands at the forefront of innovation and excellence and...
    John D. Denstedt, Evangelos N. Liatsikos
    Book 2023
  6. SLC14A1 is a new biomarker in renal cancer

    Background

    Renal cancer is one of the common malignant tumors of the urinary tract, prone to distant metastasis and drug resistance, with a poor...

    Zhengqiang Wan, Yinglei Wang, ... Dongbing Zheng in Clinical and Translational Oncology
    Article 01 April 2023
  7. Intratumoral metastasis of sigmoid colon cancer to chromophobe renal cell carcinoma: a case report

    We herein report an extremely rare case of intratumoral metastasis of colon cancer to chromophobe renal cell carcinoma. A 71-year-old woman was...

    Suzuna Sakai, Kojiro Ohba, ... Yasuto Yamazaki in International Cancer Conference Journal
    Article Open access 03 February 2024
  8. Definitive chemoradiotherapy for a patient with anal cancer after renal transplantation

    Patients after renal transplantation are susceptible to secondary malignancies, including anal squamous cell carcinoma. Chemoradiotherapy is the...

    Takeshi Kashiwagi, Katsuyuki Sakanaka, ... Takashi Mizowaki in International Cancer Conference Journal
    Article 20 March 2024
  9. iMN041 is an immunotherapeutic and an effective treatment in mouse xenograft models of pancreatic cancer, renal cancer and triple negative breast cancer

    Background

    iMN013 (5-aza-2',2'-difluorodeoxycytidine), a DNA methyl transferase inhibitor and ribonucleotide reductase inhibitor, and its prodrug...

    Richard Daifuku, Yu Zhang, ... Qingyang Gu in Translational Medicine Communications
    Article Open access 19 January 2024
  10. Diagnostic liquid biopsy biomarkers in renal cell cancer

    The clinical presentation of renal cell cancer (RCC) is shifting towards incidental and early detection, creating new challenges in RCC diagnosis....

    Richard C. Zieren, Patricia J. Zondervan, ... Adriaan D. Bins in Nature Reviews Urology
    Article 27 September 2023
  11. Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update

    Purpose

    Renal cell carcinoma is an aggressive disease with a high mortality rate. Management has drastically changed with the new era of...

    Andrey Soares, Fernando Sabino Marques Monteiro, ... Stênio de Cássio Zequi in Journal of Cancer Research and Clinical Oncology
    Article Open access 09 April 2024
  12. The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience

    Background

    Due to the presence of other comorbidities and multi-therapeutic modalities in breast cancer, renally cleared chemotherapeutic regimens may...

    Yi-Wen Hong, I-Ming Kuo, ... Hsu-Huan Chou in Breast Cancer
    Article Open access 27 December 2023
  13. Elevation of cancer antigen 15-3 owing to oncocytic renal neoplasm in a patient without evidence of breast cancer recurrence on follow-up: a case report

    Background

    Cancer antigen 15-3 is a protein that clinicians commonly measure to monitor outcomes and response to treatment in patients with breast...

    Samuel G. Cockey, Hongzhi Xu, Mohammed Al-Jumayli in Journal of Medical Case Reports
    Article Open access 07 December 2023
  14. Justifying Ribociclib Dose in Patients with Advanced Breast Cancer with Renal Impairment Based on PK, Safety, and Efficacy Data: An Innovative Approach Integrating Data from a Dedicated Renal Impairment Study and Oncology Clinical Trials

    Background and Objective

    Renal impairment is common in patients with cancer and can alter the PK and thus the safety and efficacy of drugs. We...

    Yan Ji, Vitaly Yartsev, ... Michelle Miller in Clinical Pharmacokinetics
    Article Open access 17 February 2023
  15. Successful pre-surgical treatment with carboplatin and gemcitabine chemotherapy for a patient with muscle-invasive bladder cancer and severe renal dysfunction

    Radical cystectomy is the standard treatment for muscle-invasive bladder cancer, and pre-surgical treatment can improve survival. Carboplatin and...

    Shota Torii, Tomoya Narita, ... Norio Takimoto in International Cancer Conference Journal
    Article 06 March 2024
  16. Nephrectomy and IVC thrombectomy in renal cancer: a narrative review

    Renal cell carcinoma accounts for two to three percent of adult malignancies and can lead to inferior vena cava (IVC) thrombosis. This condition can...

    Ali Faegh, Aysan Moeinafshar, Nima Rezaei in Clinical and Translational Oncology
    Article 11 August 2023
  17. Comparison of the risks of renal cell carcinoma or urothelial cancer between hemodialysis and peritoneal dialysis patients

    Purpose

    This study is to compare risks of develo** renal cell carcinoma or urothelial cancer between hemodialysis (HD) and peritoneal dialysis (PD)...

    I-Kuan Wang, Tung-Min Yu, ... Fung-Chang Sung in International Urology and Nephrology
    Article 01 March 2023
  18. A Case of Recurrent Ovarian Cancer with Renal Dysfunction Associated with the Use of Olaparib

    Olaparib (ORB) is known not to largely affect renal function due to its specific pharmacological mechanism, and there are no reports on renal...

    Yukiko Yamano, Tomokazu Minakata, ... Seiji Hashimoto in SN Comprehensive Clinical Medicine
    Article 13 January 2023
  19. The impact of the COVID-19 pandemic on renal cancer care

    Purpose

    To evaluate the impact of the COVID-19 pandemic on renal cell carcinoma (RCC) care in the Netherlands.

    Methods

    Newly diagnosed RCCs between...

    Hilin Yildirim, Adriaan D. Bins, ... Katja K. H. Aben in World Journal of Urology
    Article Open access 13 April 2024
  20. Prospective evaluation of hematological parameters in preoperative renal cell cancer patients

    Background

    Of all the genitourinary cancers, renal cell carcinoma (RCC) is still the most common malignancy with high mortality rates. There are still...

    Ozden Demir, Guzin Demirag, Gokhan Aslan in BMC Urology
    Article Open access 10 December 2022
Did you find what you were looking for? Share feedback.